Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
Portfolio Pulse from Kaustubh Bagalkote
Cathie Wood's ARK Innovation ETF (ARKK) has seen a sharp decline, with a 72% drop since its peak in February 2021. Among its top holdings, only Tesla has shown a positive return. The ten largest losers within ARKK include Ginkgo Bioworks, Teladoc Health, Pacific Biosciences, 10x Genomics, Unity Technologies, Verve Therapeutics, Zoom Video, Roku, UiPath, and Intellia Therapeutics.
May 28, 2024 | 11:29 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ARK Innovation ETF has declined by 72% since its peak in February 2021, underperforming its benchmark, the Nasdaq 100.
The significant decline in ARKK's value compared to its benchmark indicates poor performance, likely leading to negative sentiment among investors.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Ginkgo Bioworks has seen a 93.4% decline in its stock price since joining ARKK.
The massive decline in Ginkgo Bioworks' stock price reflects poor performance, likely leading to negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Intellia Therapeutics has experienced a 59.9% decline in its stock price since joining ARKK.
The notable decline in Intellia Therapeutics' stock price indicates poor performance, likely leading to negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Pacific Biosciences has seen a 90.2% decline in its stock price since joining ARKK.
The substantial decline in Pacific Biosciences' stock price reflects poor performance, likely leading to negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
UiPath has seen a 69.5% decline in its stock price since joining ARKK.
The significant decline in UiPath's stock price reflects poor performance, likely leading to negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Roku has experienced a 77.0% decline in its stock price since joining ARKK.
The substantial decline in Roku's stock price indicates poor performance, likely leading to negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Teladoc Health has experienced a 93.0% decline in its stock price since joining ARKK.
The significant decline in Teladoc Health's stock price indicates poor performance, likely leading to negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
10x Genomics has experienced an 85.0% decline in its stock price since joining ARKK.
The notable decline in 10x Genomics' stock price indicates poor performance, likely leading to negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Unity Technologies has seen an 81.2% decline in its stock price since joining ARKK.
The significant decline in Unity Technologies' stock price reflects poor performance, likely leading to negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Verve Therapeutics has experienced an 81.0% decline in its stock price since joining ARKK.
The substantial decline in Verve Therapeutics' stock price indicates poor performance, likely leading to negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Zoom Video has seen a 77.6% decline in its stock price since joining ARKK.
The significant decline in Zoom Video's stock price reflects poor performance, likely leading to negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
POSITIVE IMPACT
Tesla is the only stock among ARKK's top 10 holdings that has shown a positive return since joining the portfolio.
Tesla's positive return amidst ARKK's overall decline highlights its strong performance, likely leading to positive sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80